Class 4 Medicines Defect Information: Pfizer Limited, Depo-Medrone with Lidocaine 40 mg/mL (1 mL and 2 mL vials – single vial preparations)

Pfizer Limited have informed the Medicines and Healthcare products Regulatory Agency that an outdated version of the Patient Information Leaflet (PIL) has been included in the packaging of  specific batches.

Further information, the affected batches and advice for healthcare professionals is available on the MHRA website.